Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.

Brent N. Rexer, Carlos L. Arteaga

Research output: Contribution to journalReview articlepeer-review

219 Scopus citations

Fingerprint

Dive into the research topics of 'Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.'. Together they form a unique fingerprint.

Medicine & Life Sciences